Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 135 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.
How did CSPHF's recent EPS compare to expectations?
The most recent EPS for CStone Pharmaceuticals is $, expectations of $.
How did CStone Pharmaceuticals CSPHF's revenue perform in the last quarter?
CStone Pharmaceuticals revenue for the last quarter is $
What is the revenue estimate for CStone Pharmaceuticals?
According to of Wall street analyst, the revenue estimate of CStone Pharmaceuticals range from $ to $
What's the earning quality score for CStone Pharmaceuticals?
CStone Pharmaceuticals has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does CStone Pharmaceuticals report earnings?
CStone Pharmaceuticals next earnings report is expected in
What are CStone Pharmaceuticals's expected earnings?
CStone Pharmaceuticals expected earnings is $, according to wall-street analysts.
Did CStone Pharmaceuticals beat earnings expectations?
CStone Pharmaceuticals recent earnings of $ expectations.